Sinopharm
1099.HK
#2226
Rank
โ‚น740.91 B
Marketcap
โ‚น237.42
Share price
0.49%
Change (1 day)
7.44%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.199 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.199 Trillion. In 2024 the company made a revenue of โ‚น7.199 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.586 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.199 T-5.1%
2023โ‚น7.586 T5.42%
2022โ‚น7.196 T-2.1%
2021โ‚น7.350 T16.85%
2020โ‚น6.290 T14.95%
2019โ‚น5.472 T21.52%
2018โ‚น4.503 T5.93%
2017โ‚น4.251 T27.22%
2016โ‚น3.341 T5.37%
2015โ‚น3.171 T9.14%
2014โ‚น2.905 T17.22%
2013โ‚น2.478 T25.94%
2012โ‚น1.968 T34.61%
2011โ‚น1.462 T55.34%
2010โ‚น941.23 B35.79%
2009โ‚น693.16 B37.56%
2008โ‚น503.91 B31.43%
2007โ‚น383.41 B40.26%
2006โ‚น273.35 B